Patent Yard Sign in
Canadian application, no grantCanada

Naphthothiopyranone derivatives

CA 2086013 A1 · Owner: Hatayama, Katsuo · Inventors: Nakashima, Yoshimoto; Hatayama, Katsuo; Sano, Tatsuhiko

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A naphthothiopyranone derivative represented by the formula:, . (wherein R1 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms) and an acid addition salt thereof have more excellent antagonist effect at serotonin 3 receptors than the prior art compounds and the effects based thereon, e.g. anti-vomiting effect gastrointes-, tinal movement regulating effect and anti-anxiety effect.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 20, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 20, 2011.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 20, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 20, 1991
GrantedNo grant recorded
Term endedJune 20, 2011
Patent numberCA 2086013 A1
Classification (IPC)C07D409/06 +2 more

Timeline

Timeline From CIPO dates

1992199419961998200020022004200620082010Application filedJune 20, 1991Term endedJune 20, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.